NDC codes

FDA NDC Directory
Product NDC (as listed)63629-9309Labeler and product segments. Claims need a package NDC.
Product NDC at billing width63629-9309Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
63629-9309-1636299309011 TUBE in 1 CARTON (63629-9309-1) / 60 g in 1 TUBEMarketed from Jul 6, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Clindamycin Phosphate
Generic name (nonproprietary)
clindamycin phosphate
Active ingredients
Clindamycin phosphate — 10 mg/g
Dosage form
Gel
Route
Topical
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 212104
Marketing start
Listing expires
Other FDA classes
Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
Identifiers
Product ID 63629-9309_f562bf25-9ad3-46ad-833a-ad4ae236a085SPL ID f562bf25-9ad3-46ad-833a-ad4ae236a085SPL set ID 51206b1e-f327-47a9-9cb3-e71f9d0c2dffRxCUI 2676585UNII EH6D7113I8
Pharmacologic class
Lincosamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463629930901 followed by a unit qualifier and the quantity

Package 63629-9309-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE Clindamycin Phosphate Gel is indicated in the treatment of acne vulgaris. In view of the potential for diarrhea, bloody diarrhea and pseudomembranous colitis, the physician should consider whether other agents are more appropriate (see CONTRAINDICATIONS , WARNINGS and ADVERSE REACTIONS ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 212104

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212104
ProductStrengthForm · routeLabelerProduct NDC
Clindamycin PhosphateClindamycin phosphate 10 mg/gGelTopicalPadagis Israel Pharmaceuticals Ltd45802-900
Clindamycin PhosphateClindamycin phosphate 10 mg/gGelTopicalBryant Ranch Prepack72162-1436
Clindamycin PhosphateClindamycin phosphate 10 mg/gGelTopicalBryant Ranch Prepack63629-8631
Clindamycin PhosphateClindamycin phosphate 10 mg/gGelTopicalBryant Ranch Prepack63629-8630

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in